✨The #ESTRO25 Congress Report is out!
📌Green Journal/The Lancet OncolOGY joint session
📌Award-winning papers
📌Track & technique highlights
👉 bit.ly/4nYNI9o
Will your study appear in the report next year?
✅Submit your abstract by 12 Nov! #ESTRO26 bit.ly/4lxLf4o

At #ESTRO25, the RTT pre-meeting course empowered RTTs to lead, collaborate, and innovate in clinical research.
Discover how this dynamic course built skills, confidence, and a research-driven community.
👉 bit.ly/3J7ZxLq
#RTTsInResearch #RadiationTherapy #RTT

🚨 #Lungcancer breakthroughs at #ESTRO25!
From osimertinib after chemoRT in unresectable EGFR-mutant NSCLC to #SBRT dose precision and ctDNA insights post-SABR, the lung sessions delivered key updates on optimising treatment and tracking response.
👉 bit.ly/4mT4vdI

Can we move beyond rigid margins and binary targets in radiotherapy? Probabilistic approaches are redefining treatment planning: more accurate, personalised & robust.
💡 Explore the key concepts contained in the latest ICRU report presented at #ESTRO25:
👉 bit.ly/3HoZaeP

⚡ From physics to preclinical trials, #FLASH #radiotherapy took the spotlight at #ESTRO25.
Discover the breakthroughs, unanswered questions, and bold steps toward clinical implementation, capturing the excitement and complexity of this rapidly evolving field.
👉 bit.ly/4lvcsV7 #RadiationOncology

Reirradiation report 5/5: from new RTT-led roles to #brachytherapy breakthroughs and next-gen approaches like #FLASH & carbon ions, #ESTRO25 showcased how #reirradiation is reshaping cancer care.
👉 bit.ly/45hJJOL
#radonc

#ESTRO25 Reirradiation Report 4/5: #lungcancer
From beam-angle optimisation with EQD2 integration to inter-centre QA and real-world survival data: explore how dosimetry, image registration, and SBRT are shaping curative reirradiation in thoracic tumours:
👉https://bit.ly/46jHPhD

🤖 From automation to true adaptation, AI took centre stage at #ESTRO25.
Explore the key themes from this year’s congress, from foundation models & clinical integration to #AI guidelines, MRIgRT, and the road to #adaptive #radiotherapy.
👉 bit.ly/4oqqmdV #Radonc #AIinRT

🏆 Best Radiobiology Paper | #ESTRO25
RAD54L & PSMC3IP: key drivers of #DNArepair, stemness & #radioresistance in #HNSCC.
Findings suggest new synthetic lethality with PARP inhibitors.
👉 bit.ly/4lu1Cij

🔥 Should we move away from elective nodal irradiation in #HeadAndNeckCancer? A lively debate at #ESTRO25 explored tradition vs innovation, weighing toxicity, recurrence, and risk-adapted strategies.
👉 Read the debate summary: bit.ly/4lf9kMX
#Radonc #radiotherapy

🏆 Award-winning innovation at #ESTRO25!
The ESTRO-Elekta Brachytherapy Award went to a study that had used electromagnetic tracking to prevent patient mix-ups in breast brachytherapy — 99.7% correct classification, 0% false positives.
👉 bit.ly/4kYYieN

#PatientSafety #Brachytherapy #Radiotherapy

#ESTRO25 reirradiation report 2/5:
How do physics & biology guide safe, effective #reirradiation? From EQD2 to dose accumulation challenges, the focus group explores:
✅ Planning
✅ Radiobiological modelling
✅ Workflows
💡 Tools & guidelines:
👉 bit.ly/3H2oxD3 #radonc

#ESTRO25 reirradiation report 1/5:
From new ESTRO-EANO guidelines to insights from GLIAA & RTOG 1205 trials, and survival data in paediatric DIPG/DMG, explore how #reirradiation is becoming a key strategy in recurrent #glioma care.
👉 bit.ly/40tH69V

📌 Missed the key #breastcancer #radiotherapy sessions at #ESTRO25?
✅ Catch up with trial updates (FAST-Forward, Skagen), #safety data, #AI, & care for young patients.
👉 Access the full breast report: bit.ly/4liVTg5 #radonc

🔥 Debate at #ESTRO25: Is the promise of AI & mathematical oncology in personalised medicine overhyped?
Experts clashed. Minds changed. Votes shifted.
📉 From 46% → 41% for the motion
📈 From 54% → 59% against
👉Read the full debate recap: bit.ly/3I9Qkld

#ESTRO25 mini-oral session on Positioning & Immobilisation showcased how tech + teamwork are reshaping radiotherapy. From SGRT to MR-Linac & AI-driven workflows, #RTTs play a key role in driving innovation in precise #radiotherapy.
👉 bit.ly/4lyVHcq

💡Explore the latest breakthroughs in #CNS #radiationoncology as presented at #ESTRO25 — from simulation-free planning and LET-guided dose sculpting to #adaptiveRT and next-gen imaging biomarkers.
👉 bit.ly/450oWxZLink
#CNSOncology #Radonc #NeuroOncology #BrainMetastases

🏆 Discover how this award-winning project on target & OAR definition in rectal HDR brachytherapy, honoured at #ESTRO25, aims to standardise care and improve outcomes in rectal cancer treatment.
👉 bit.ly/3TXTYRU
#Brachytherapy #GIoncology #RadiationOncology #OrganPreservation #rectalcancer

👥Struggling to recruit & retain RTTs?
At #ESTRO25, experts from various countries shared practical, proven ways to strengthen the #RTT #workforce that ranged from career development & mental health to public awareness & employer branding.
👉 bit.ly/403kCwb
#Radiotherapy

Is robust immobilisation in #radiotherapy a thing of the past?
At #ESTRO25, #RTTs debated whether tech like SGRT, ART & real-time imaging make traditional positioning obsolete.
From patient comfort to treatment accuracy, see arguments & audience vote:
👉 bit.ly/4kp7ybY

The 10-year results of the HYPO-RT-PC trial, presented at #ESTRO25, confirm that ultra-hypofractionated #radiotherapy is a safe, effective option for localised #prostatecancer — with strong evidence and long-term follow-up to back it up.
👉 bit.ly/3T3jc0X

Can AI flag its own blind spots? At #ESTRO25, researchers showed how uncertainty quantification in auto-segmentation helps in the detection of out-of-distribution cases like CTs with metal artefacts.
👉 bit.ly/4nyeqGw
#medicalphysics #QA #medphys #radonc

🏆 Best Paper Award – Interdisciplinary at #ESTRO25
How can we evaluate the cost of #radiotherapy innovations? An upgraded version of the ESTRO-HERO model supports integration of innovation & flexible resource allocation.
👉 bit.ly/4lvZ17K #HealthEconomics

#Radiotherapy + #Immunotherapy: A perfect combo?
At #ESTRO25, experts explored how RT can reprogramme the tumour microenvironment to boost immune response.
Curious how RT can train the immune system?
👉Read the report of the session: bit.ly/3IaBSJX
#radiobioly #radonc

At #ESTRO25, a heated debate unfolded: “CBCT-based fast adaptation workflows will supersede MR-Linac usage.”
💬 With strong arguments on both sides, the audience shifted from 72% in favour to a near 50/50 split by the end.
👉 bit.ly/3Iavy59

🏆 CtRO Young Researcher Award #ESTRO25
Why are locoregional recurrences higher after TNT in #rectalcancer? RAPIDO team found the risk rises only after sphincter-preserving surgery with ≤10mm distal margin likely due to TNT’s fragmented tumour response.
👉https://bit.ly/45PORdH

💔 Who’s most at risk of heart issues after #breastcancer #radiotherapy?
💡 New #ESTRO25 data from the EU TETRIS project: cardiac calcifications—especially Max_HU—can predict post-RT cardiotoxicity.
👉 bit.ly/3TQ1HRU
#medphys #radiotherapy #radonc

💥 PEACE-V STORM final results at #ESTRO25: ENRT beats MDT for oligorecurrent nodal prostate cancer.
✔️ Better MFS (76% vs. 63%)
✔️ Improved control
✔️ Similar toxicity, fewer treatments
👉 bit.ly/46bHU6N

#Radiotherapy in mutation-driven #NSCLC: key highlights from #ESTRO25
📌 Joint ESTRO-IASLC Symposium
📌 Proffered Papers Session
📌 Clinical trial updates – LAURA, HALT, BOUNCE, HORIZON-1
👉 bit.ly/4nh4L70 #LungCancer

📢The joint #CallForAbstracts with
@TheLancetOncol
& Radiotherapy & Oncology led to 3,485 clinical abstracts at #ESTRO25 – the highest ever!
📍Up next:: #ESTRO26 in Stockholm with a dedicated clinical trials session!
ℹ️https://bit.ly/4leXqTY
#Radonc